MedTrace Logo

HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels

NCT04610762 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2023-05-06

No results posted yet for this study

Summary

The main objective of this study is to assess the interest (linkage to care) of the Cepheid GeneXpert HCV VL Fingerstick test in Brussels among drug users or former users in contact with the Réseau Hépatite C Bruxelles organization through different partners of this network.

Conditions

  • Hepatitis C, Chronic

Interventions

DIAGNOSTIC_TEST

GeneXpert HCV VL Fingerstick test

The participants will have a molecular test (GeneXpert HCV VL Fingerstick, Cepheid) that quantifies hepatitis C virus (HCV) RNA levels directly from a fingerstick blood sample.

Sponsors & Collaborators

  • Cepheid

    collaborator INDUSTRY

  • Réseau Hépatite C Bruxelles

    collaborator UNKNOWN

  • Gilead Sciences

    collaborator INDUSTRY

  • AbbVie

    collaborator INDUSTRY

  • Centre Hospitalier Universitaire Saint Pierre

    lead OTHER

Principal Investigators

  • Jean-Pierre Mulkay, MD · Centre Hospitalier Universitaire Saint Pierre

  • Lise Meunier, MD · ASBL Réseau Hépatite C Bruxelles

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-17
Primary Completion
2021-11-17
Completion
2022-11-17

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04610762 on ClinicalTrials.gov